阿司匹林的研发历史与作用机制概述.pptVIP

* The Physicians’ Health Study1 was stopped early, after approximately 5 years of follow-up. This slide summarises the key findings from the trial. Overall, there was a highly significant and impressive 44% reduction in the risk of first myocardial infarction (MI) was observed in the aspirin group. The incidence of fatal MI was also significantly reduced by 66%, and nonfatal MI was significantly reduced by 41%. The total number of severe vascular incidents, such as nonfatal MI, nonfatal stroke and cardiovascular (CV) death, were significantly reduced by 18% in the aspirin group. 1. Steering C